Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2003
11/27/2003US20030220487 Flea peritrophin nucleic acid molecules, proteins and uses thereof
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220473 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein
11/27/2003US20030220289 Compositions for delivering nucleic acids to cells
11/27/2003US20030220288 Nor-1 and nur77 nuclear receptors as targets for anti-leukemia therapy
11/27/2003US20030220287 Inhibit expression of anthrax toxin receptor mRNA and human tumor endothelial marker 8
11/27/2003US20030220286 Undetectable biological effect in the absence of an inducer, but which exhibits efficient inducibility in the presence of an inducer.
11/27/2003US20030220284 Adenoviral DNA comprises a circular form; and a therapeutic polynucleotide.
11/27/2003US20030220283 Including injection of a vector molecule containing the DNA sequence encoding for a product of interest, or non-viral introduction of such a DNA sequence, to one joint of a mammalian host
11/27/2003US20030220282 Antisense modulation of PTP1B expression
11/27/2003US20030220281 To inhibit the activity of elastase or cathepsin G, thereby inhibiting ectopic implantation of endometrial fragments.
11/27/2003US20030220280 Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate CNS nerve regeneration
11/27/2003US20030220279 Decreasing cell proliferation by decreasing levels of PP5
11/27/2003US20030220278 Introducing into the T cell a nucleic acid encoding B- Raf operably linked to a promoter; thereby inducing the T cell to proliferate in response to the antigen.
11/27/2003US20030220277 Methylation of plasmid vectors
11/27/2003US20030220275 Antisense modulation of kinesin-like 1 expression
11/27/2003US20030220274 Plasmid comprising a chicken beta actin promoter and enhancer; a modified GLP-1 (7-37) cDNA (p beta GLP1), carrying a furin cleavage site
11/27/2003US20030220262 Prevention and treatment of endothelial injury and the injury of tissues containing injured blood vessels by administration of vascular endothelial cell growth factor
11/27/2003US20030220250 Angiopoietin-1 in the treatment of disease
11/27/2003US20030220247 Enhanced gamma-carboxylation of recombinant vitamin K-dependent clotting factors
11/27/2003US20030220245 Conjugate addition reactions for the controlled delivery of pharmaceutical active compounds
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder
11/27/2003US20030219909 Materials containing multiple layers of vesicles
11/27/2003US20030219895 An oligonucleotide or a hybrids for encoding a protein kinase
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219860 Comprises nucleotide sequences coding novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents
11/27/2003US20030219859 Preparing viral protein 22 (VP22) for use as gene therapeutic tool in treatment of cancer; drug delivery
11/27/2003US20030219858 Novel heteromultimeric ion channel receptor and uses thereof
11/27/2003US20030219823 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/27/2003US20030219794 Comprises nucleotide sequences coding enzymatic polypeptide associated with purine nucleotide biosynthesis for use as cancer diagnositic markers; antiproliferative/antitumor agents
11/27/2003US20030219789 36P6D5: secreted tumor antigen
11/27/2003US20030219768 Lung cancer therapeutics and diagnostics
11/27/2003US20030219739 Comprises muscle protein for treating and preventing of muscle atrophy
11/27/2003US20030219735 Genetically engineered adeno-associated viral vector comprising single stranded heterologous nucleotide sequence for use as tool diagnostic tool in gene therapy and genomic screening
11/27/2003US20030219733 Antibody gene transfer and recombinant AAV therefor
11/27/2003US20030219728 Comprises nucleotide sequences coding HIV-associated life preserver (HALP) protein for treating apoptosis disorders; viricides; antiapoptosis; genetic vaccines
11/27/2003US20030219474 A polynucleotide that hybridizes to a Bcl-2-encoding polynucleotide and a lipid associated with such polynuclotide
11/27/2003US20030219458 Multivalent vaccination using recombinant adenovirus
11/27/2003US20030219435 Method of reducing an immune response to a recombinant virus
11/27/2003US20030219426 Endostatins used as antiproliferative agents or angiogenesis inhibitors for prophylaxis of tumors, or as contraceptives
11/27/2003US20030219424 Polynucleotide codes for amino acid sequences used for medical diagnosis, prophylaxis autoimmune diseases, as antiallergens or antitumor agents
11/27/2003US20030219423 Methods of inducing or enhancing connective tissue repair
11/27/2003US20030219422 Polyucleotides having hammerhead motif used for detection and analysis; biosensors
11/27/2003US20030219421 Genetic vectors comprising polynucleotide codes for vitamin D-dependent calcium binding protein, administered for prevention of apoptosis in cells and prophylaxis of osteoporosis
11/27/2003US20030219415 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
11/27/2003US20030219414 A gene therapy transfecting a host cell, promoting gene transcription and translation, encoding beta-glucuronidase, sustained expression of the defective or missing enzyme
11/27/2003US20030219413 Method for overexpression of zwitterionic polysaccharides
11/27/2003US20030219412 Somatic gene therapy to suppress secondary cataract formation following eye surgery
11/27/2003US20030219411 Modulators of the function of FAS receptors and other proteins
11/27/2003US20030219410 Adenoviral vectors for modulating the cellular activities associated to PODs
11/27/2003US20030219409 Eukaryotic gene expression cassette and uses thereof
11/27/2003US20030219376 Progression elevated Gene-3 and uses thereof
11/27/2003CA2752143A1 Delivery of nucleic acid-like compounds
11/27/2003CA2486583A1 Marker molecules associated with lung tumors
11/27/2003CA2486576A1 Sodium channel regulators and modulators
11/27/2003CA2486327A1 Htlv-i tax induced killing of p53 null cancer cells
11/27/2003CA2485969A1 Carotene synthase gene and uses therefor
11/27/2003CA2484295A1 Attenuation of metapneumovirus
11/27/2003CA2482458A1 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
11/27/2003CA2390972A1 Bovine viral diarrhea virus (bvdv) p80 and p80.delta.50 proteins as inducers of cell apoptosis
11/27/2003CA2383607A1 Bovine viral diarrhea virus (bvdv) p80 and p80.delta.50 proteins as inducers of cell apoptosis in vitro
11/26/2003EP1365246A1 Diagnostics and therapeutics for diseases associated with neuromedin U2 receptor (NMU2)
11/26/2003EP1365034A2 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
11/26/2003EP1365032A1 Marker molecules associated with lung tumors
11/26/2003EP1365027A2 Fas ligand-fused proteins
11/26/2003EP1365022A1 Adiponectin-associated protein
11/26/2003EP1364962A1 Use of monocarboxylate transporter proteins for thyroid hormone transport
11/26/2003EP1364038A2 Adenovirus particles with mutagenized fiber proteins
11/26/2003EP1364028A2 Regulation of human carboxypeptidase a
11/26/2003EP1364025A1 A novel gene bn01 mapping to chromosome 16q24.3
11/26/2003EP1364021A2 Compositions and methods relating to colon specific genes and proteins
11/26/2003EP1364019A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
11/26/2003EP1364017A2 Inflammation related g-protein coupled receptor
11/26/2003EP1364015A2 Molecules for diagnostics and therapeutics
11/26/2003EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/26/2003EP1364009A2 Regulatable, catalytically active nucleic acids
11/26/2003EP1364008A2 Methods for enhancing targeted gene alteration using oligonucleotides
11/26/2003EP1364004A2 Administration of nucleic acid sequence to female animal
11/26/2003EP1363997A1 Concentration and lysis of adenovirus-infected cells in a single unit operation
11/26/2003EP1363995A2 Use of a composition with antioxidant activity for conditioning stem cells
11/26/2003EP1363948A1 Polypeptide of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids coding therefor and use thereof
11/26/2003EP1363943A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/26/2003EP1363942A2 Polypeptide from a hdm2 protein specific murine alpha/beta t-cell receptors, nucleic acids coding for the above and use thereof
11/26/2003EP1363940A1 Tumour peptide antigen produced from human mdm2 proto-oncogene
11/26/2003EP1363933A2 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances
11/26/2003EP1363932A2 Amphoteric sterols and the use thereof
11/26/2003EP1363676A2 Method of enhancing delivery of a therapeutic nucleic acid
11/26/2003EP1363675A2 Compositions useful in gene therapy
11/26/2003EP1363670A1 Polynucleotide formulation for enhanced intracellular transfer
11/26/2003EP1363663A2 Nucleic acid mucosal immunization
11/26/2003EP1363662A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo ; analysis of vaccinating composition in vitro
11/26/2003EP1363660A2 Superior molecular vaccine based on self-replicating rna, suicidal dna or naked dna vector, that links antigen with polypeptide that promotes antigen presentation
11/26/2003EP1363658A2 Local pain-combating agent
11/26/2003EP1363640A2 Nucleic acid derivatives
11/26/2003EP1363528A2 Methods for diagnosing and treating heart disease
11/26/2003EP1224471B1 Dpi-6, a therapeutic biomarker in neurological disorders
11/26/2003EP0888123B1 Antagonism of endothelin actions
11/26/2003CN1458977A Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
1 ... 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 ... 870